Drug Screening Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET OVERVIEW

Drug screening is a technical process, performed for analyzing specimens such as hair, urine, oral fluids, breath and other samples. Drug screening aids in detection of drug or a chemical compound in the body. This process is applied in hospitals, drug testing centers, pain management centers as well as law enforcement agencies. Drug screening tests are also performed by companies and organizations on employees and athletes to check for drug abuse.

MARKET SCOPE

The "Global Drug Screening Market Analysis to 2031" is a specialized and in-depth study of the food and beverages industry with a special focus on the global market trend analysis. The report aims to provide an overview of the drug screening market with detailed market segmentation by type, products, Disease Detection, application, and geography. The report provides key statistics on the market status of the leading drug screening market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

• Based on product type, the market is segmented as analytical instruments, rapid testing devices and consumables.
• On the basis of sample, the global drug screening market is segmented into breath, hair, oral fluid, urine and others.
• Based on end user, the market is bifurcated into drug testing laboratories, drug treatment centers, criminal justice systems & law enforcement agencies, pain management centers, hospitals, individuals and others

MARKET DYNAMICS
Drivers

• Increase consumption of alcohol and drugs during the previous years, has been a matter of concern for various employers.
• Various government bodies have been providing funds for drug screening tests.
• Development and adoption of new methods as well as devices for drug screening is anticipated to be the driving factors for the growth of drug screening market.

Restraints

• Bans on alcohol consumption in Islamic countries is likely to restraint the market growth.
• Prohibition of drug testing at workplace

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The drug screening market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the drug screening market in these regions.

IMPACT OF COVID-19 ON DRUG SCREENING MARKET

COVID-19 has ended in significant disruptions to businesses and commercial activities globally. Restrictions and lockdowns were also imposed in travel, business operations, public gatherings, and shelter-in-place orders, all of which have further impacted market growth. However, it is expected to have a short-term negative influence on the drug screening market due to the limited or non-availability of medical departments or treatment centers, harm-reducing service providers, and the fear of infection transmission. In addition, various authorities worldwide provided guidelines to postpone or delay non-essential medical and surgical systems to reduce the strain on the healthcare system and decrease disease transmission.

Drug Screening Market Report Analysis

Drug Screening Market

• 
  CAGR (2023 - 2031)

  XX%
• Market Size 2023
  US$ XX Million
• Market Size 2031
  US$ XX Million

Report Coverage

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis

• Industry landscape and competition analysis & recent developments
• Detailed company profiles

• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

• Abbott
• Omega Laboratories, Inc.
• Roche Monitoring Services.
• Siemens Healthcare GmbH
• Thermo Fisher Scientific Inc.
• Quest Diagnostics Incorporated
• Premier Biotech, Inc.
• OraSure Technologies, Inc.
• Psychemedics Corporation

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

By Product Type

• Analytical Instruments
• Rapid Testing Devices
• Consumables

By Sample Type

• Breath
• Hair
• Oral Fluid
• Urine

By End User

• Drug Testing Laboratories
• Drug Treatment Centers
• Pain Management Centers
• Criminal Justice Systems and Law Enforcement Agencies
• Hospitals

MARKET PLAYERS

The report covers key developments in the drug screening market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from drug screening market are anticipated to lucrative growth opportunities in the future with the rising demand for drug screening in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the drug screening market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

• Abbott
• Omega Laboratories, Inc.
• Roche Monitoring Services.
• Siemens Healthcare GmbH
• Thermo Fisher Scientific Inc.
• Quest Diagnostics Incorporated
• Premier Biotech, Inc.
• OraSure Technologies, Inc.
• Psychemedics Corporation
• Laboratory Corporation of America Holdings

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Drug Screening Market Report Scope